| Abstract: |
Cancer arises from a single cell through a series of acquired mutations and epigenetic alterations. Tumors gradually develop into a complex tissue comprised of phenotypically heterogeneous cancer cell populations, as well as noncancer cells that make up the tumor microenvironment. The phenotype, or state, of each cancer and stromal cell is influenced by a plethora of cell-intrinsic and cell-extrinsic factors. The diversity of these cellular states promotes tumor progression, enables metastasis, and poses a challenge for effective cancer treatments. Thus, the identification of strategies for the therapeutic manipulation of tumor heterogeneity would have significant clinical implications. A major barrier in the field is the difficulty in functionally investigating heterogeneity in tumors in cancer patients. Here we review how mouse models of human cancer can be leveraged to interrogate tumor heterogeneity and to help design better therapeutic strategies. Copyright © 2020 by Annual Reviews. |
| Keywords: |
review; nonhuman; cancer patient; phenotype; metastasis; epigenetics; cancer stem cell; tumor model; tumor growth; stroma cell; genetic heterogeneity; mouse model; tumor microenvironment; human; priority journal; malignant neoplasm; tumor heterogeneity, mouse models, genetics, epigenetics, tumor microenvironment, cancer stem cells
|
